Major Medtech Business Moves from Stryker, STERIS
Stryker announces a $400 million preferred equity investment in surgical robotics developer CMR Surgical, while STERIS expands its consumables portfolio with the planned acquisition of Xodus Medical.
AdobeStock | 198960468
Clare Scott, Managing Editor - Manufacturing Group, published this article on October 15, 2026.
Key Takeaways:
- Strategic Investment: Stryker invests approximately $400 million (£300 million) in CMR Surgical, with an option to acquire the remaining equity.
- Partnership: The collaboration brings CMR Surgical's robotics portfolio and clinical experience to Stryker's scale and market reach.
- Market Opportunity: The alliance aims to expand robotic-assisted surgery programs, leveraging CMR Surgical's second-generation robot, Versius.
- Scalable Solution: Versius' modular design supports various procedures, surgeon access, and care settings, catering to growing demand.
Quotes:
"Soft-tissue robotics is a high-growth adjacency... We selected CMR Surgical... because of the opportunity to help healthcare providers grow robotic-assisted surgery adoption." - Andy Pierce, Group President, Medsurg and Neurotechnology, Stryker
"This strategic alliance... is a significant milestone for CMR and a strong endorsement of our technology...] - Massimiliano Colella, CEO, CMR Surgical